Jonathan A Vroom

Suggest Changes
Learn More
A major limitation to improving small-molecule pharmaceutical production in streptomycetes is the inability of high-copy-number plasmids to tolerate large biosynthetic gene cluster inserts. A recent(More)
  • 1